Collects blood plasma samples from people with head and neck cancer
Collects blood plasma samples from adults with head and neck squamous cell carcinoma during treatment.
Plain-language title generated from the registry record
Registry title: Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Key facts
- Where
- Charleroi, Haine-Saint-Paul, Liège, Namur, and Ottignies, BelgiumSee the 5 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with squamous cell carcinoma of the head and neck who are treated with a molecular targeted therapy. Blood plasma samples are collected before, during and at progression of treatment.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Squamous cell carcinoma of the head and neck.
- Earlier treatment
- People must be treated with radiation therapy plus cetuximab, with cetuximab plus chemotherapy, or with a molecular targeted agent in a clinical study.
Main reasons for not taking part
- Another type of head and neck cancer
- Not treated with targeted therapies
Read by machine on 12 November 2026.
Where in Belgium
- Grand Hopital de CharleroiCharleroi, BelgiumContact: Christophe Lonchay, MDTaking people
- Centre Hospitalier Jolimont-Lobbes-Nivelles-TubizeHaine-Saint-Paul, BelgiumContact: Emmanuel Seront, MD, PhDTaking people
- CHU LiègeLiège, BelgiumContact: Maude Piron, PhDTaking people
- Clinique et Maternité Sainte-ElisabethNamur, BelgiumContact: Stéphanie Henry, MDTaking people
- Clinique Saint PierreOttignies, BelgiumContact: Renaud Poncin, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Trial code
- NCT02139020
- Record updated
- 11 December 2023
- Original description
The investigators will collect plasma samples at baseline, during treatment, and at progression.Read full original descriptionShow less
Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck
The investigators will collect plasma samples at baseline, during treatment, and at progression.
Inclusion: patients treated with radiation therapy and cetuximab according to Bonner et al; patients treated with cetuximab in combination with chemotherapy according to Vermorken et al; patients treated with a molecular targeted agent as a part of a clinical study.
Exclusion: patients non treated with targeted therapies; patients with another type of head and neck cancer.